Risk/Benefit Value Tool Could Trim Guesswork From OTC Switch Attempts
This article was originally published in The Pink Sheet Daily
The World Self Medication Industry and related trade groups created a value-tree framework with predefined major risk and benefit domains to help firms and regulators identify the opportunities and challenges a product or switch candidate poses.
You may also be interested in...
Rx-to-OTC switch questions that FDA asked advisory committees over the past 10 years can help guide future sponsors to success, says the lead researcher in an analysis of the agency’s switch actions.
More information from "real world" experiences on how consumers make OTC selections may be needed to pull off a successful Rx-to-OTC switch of a statin
FDA's review of children's over-the-counter cough/cold products will address the broader issue of whether extrapolating pediatric doses from adult dosing data is appropriate